H
Werewolf Therapeutics
HOWL
2.29000
USD
0.05
(2.23%)
مغلق
حجم التداول
10,983
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
111,440,475
العنوان: Werewolf Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.